Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.
Gupta AO, Sharma A, Frangoul H, Kanter J, Mapara MY, Dalal J, Alavi A, Jaroscak JJ, Ayala E, DiPersio JF, Ziga ED, Eapen M, Rifkin-Zenenberg S, Minella AC, Chen Y, Chesler S, Ambati S, Bowman TS, Habtemariam B, Joseney-Antoine M, Chockalingam PS, Lin L, Goyal S, Simon A, Thompson AA, Heeney MM; BEACON Investigators. Gupta AO, et al. Among authors: ambati s. N Engl J Med. 2026 May 7;394(18):1824-1835. doi: 10.1056/NEJMoa2504835. Epub 2026 Apr 1. N Engl J Med. 2026. PMID: 41931046 Clinical Trial.
Comparative effectiveness of odronextamab monotherapy versus real-world systemic therapies in R/R follicular lymphoma.
Bachy E, Harnett J, Prochazka K, Townsend W, Radford J, Serna Á, Kim TM, Kuruvilla J, Damaj GL, Jiménez-Ubieto A, Martinez-Calle N, Hampp C, Jalbert JJ, Kamat S, Ma Q, Wang J, Bajwa A, Cheung HK, Tiso S, Ambati S, Mohamed H, Chaudhry A, Xu Y, Hermans R, Park JE, Chen JMH, Mastikhina L, Rippin G, Patt R, Luminari S, Thieblemont C. Bachy E, et al. Among authors: ambati s. Leuk Lymphoma. 2026 Mar;67(4):907-918. doi: 10.1080/10428194.2026.2619500. Epub 2026 Feb 24. Leuk Lymphoma. 2026. PMID: 41736495
Stem cells in organogenesis and regeneration.
Mim TJ, Ahmad I, Basher SR, Rahman MF, Ambati SR, Venkatagiri K, Seher N, Kumar D, Choudhary N, Kondaveeti SB. Mim TJ, et al. Among authors: ambati sr. Stem Cell Res Ther. 2026 Jan 18;17(1):85. doi: 10.1186/s13287-025-04889-z. Stem Cell Res Ther. 2026. PMID: 41549301 Free PMC article. Review.
Prognostic factors and effect modifiers in patients with relapsed or refractory follicular lymphoma who failed at least two lines of therapy: a systematic literature and expert clinical review.
Abrisqueta P, Jiménez-Ubieto A, Serna Á, Zamanillo I, Kuang Y, Uyei J, Shah M, Walsh L, Thorley E, Cantos K, Rashidi E, Ma Q, Jalbert JJ, Archambault AN, Xu Y, Aggarwal S, Ambati S, Mohamed H, Hampp C, von Tresckow B. Abrisqueta P, et al. Among authors: ambati s. Ann Hematol. 2025 Sep;104(9):4357-4367. doi: 10.1007/s00277-025-06575-9. Epub 2025 Sep 2. Ann Hematol. 2025. PMID: 40892075 Free PMC article.
Patient-reported outcomes in relapsed/refractory diffuse large B-cell lymphoma with odronextamab monotherapy.
Iskierka-Jażdżewska E, Kim WS, Cho SG, Kim TM, Jarque I, Robak T, Poon M, Prince HM, Oh SY, Lim F, Carpio C, Tan TD, Ayyappan S, Gutierrez A, Zhang H, Cao J, Tessoulin B, Li J, Ivanescu C, Reaney M, Chaudhry A, Mohamed H, Ambati S, Harnett J, Chi L, Kamat S, Walewski J; ELM-2 Investigators. Iskierka-Jażdżewska E, et al. Among authors: ambati s. Leuk Lymphoma. 2025 Dec;66(12):2214-2225. doi: 10.1080/10428194.2025.2535694. Epub 2025 Aug 20. Leuk Lymphoma. 2025. PMID: 40834261 Free article. Clinical Trial.
Health-Related Quality of Life With Odronextamab Monotherapy for Relapsed/Refractory Follicular Lymphoma in the ELM-2 Study.
Tessoulin B, Harnett J, Cho SG, Taszner M, Kim TM, Novelli S, Villasboas JC, Merli M, Jiménez-Ubieto A, Poon M, Tucker D, Walewski J, Yi S, Song Y, Chong G, Bachy E, Guidez S, Alonso A, Jagadeesh D, Zhang W, Magnano Mayer L, Iskierka-Jażdżewska E, Tani M, Cai J, Ivanescu C, Reaney M, Chaudhry A, Mohamed H, Ambati S, Chi L, Kamat S, Luminari S; ELM-2 Investigators. Tessoulin B, et al. Among authors: ambati s. Clin Lymphoma Myeloma Leuk. 2025 Oct;25(10):e766-e777.e6. doi: 10.1016/j.clml.2025.05.017. Epub 2025 May 23. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40571446 Free article. Clinical Trial.
143 results